Established in 2018, this manufacturer specializes in exporting and manufacturing pharmaceutical active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, pre-filled syringes, dry syrups, creams, ointments, injectables (liquids and powder), eye/ear drops, IV fluids, and surgical products. As a CTD dossier owner and manufacturer, it holds EU/WHO GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Central America, non-EU Europe, the Middle East, Oceania, South America, and South Asia.

This CTD dossier owner and manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.